Genetics of Parkinson's Disease

Parkinson's Disease

Volumn , Issue , 2008, Pages 9-33

  Ross, Owen A ^a   Braithwaite, Adam T ^a   Farrer, Matthew J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58549112497     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374028-1.00002-6     Document Type: Chapter

References (154)

1. Aasly J.O., Toft M., Fernandez-Mata I., Kachergus J., Hulihan M., White L.R., Farrer M. Clinical features of LRRK2-associated Parkinson's disease in central Norway. Ann Neurol 2005, 57:762-765.
2. Abbas N., Lücking C.B., Ricard S., Dürr A., Bonifati V., DeMichele G., Bouley S., Vaughan J.R., Gasser T., Marconi R., Broussolle E., Brefel-Courbon C., Harhangi B.S., Oostra B.A., Fabrizio E., Bohme G.A., Pradier L., Wood N.W., Filla A., Meco G., Denèfle P., Agid Y., Brice A. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. Hum Mol Genet 1999, 8:567-574.
3. Abou-Sleiman P.M., Healy D.G., Quinn N., Lees A.J., Wood N.W. The role of pathogenic DJ-1 mutations in Parkinson's disease. Ann Neurol 2003, 54:283-286.
4. Abou-Sleiman P.M., Muqit M.M., McDonald N.Q., Yang Y.X., Gandhi S., Healy D.G., Harvey K., Harvey R.J., Deas E., Bhatia K., Quinn N., Lees A., Latchman D.S., Wood N.W. A heterozygous effect for PINK1 mutations in Parkinson's disease?. Ann Neurol 2006, 60:414-419.
5. Bagade, S., Allen, N.C., Tanzi, R., Bertram, L. The PDGene Database, Alzheimer Research Forum, Available at. http://www.pdgene.org/.
6. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999, 8:711-715.
7. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S., Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T., Zehr C., Dickey C.A., Crook R., McGowan E., Mann D., Boeve B., Feldman H., Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006, 442:916-919.
8. Bandmann O., Daniel S., Marsden C.D., Wood N.W., Harding A.E. The GTP-cyclohydrolase I gene in atypical parkinsonian patients: A clinico-genetic study. J Neurol Sci 1996, 141:27-32.
9. Bandmann O., Valente E.M., Holmans P., Surtees R.A., Walters J.H., Wevers R.A., Marsden C.D., Wood N.W. Dopa-responsive dystonia: A clinical and molecular genetic study. Ann Neurol 1998, 44:649-656.
10. Bandopadhyay R., Kingsbury A.E., Cookson M.R., Reid A.R., Evans I.M., Hope A.D., Pittman A.M., Lashley T., Canet-Aviles R., Miller D.W., McLendon C., Strand C., Leonard A.J., Abou-Sleiman P.M., Healy D.G., Ariga H., Wood N.W., de Silva R., Revesz T., Hardy J.A., Lees A.J. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 2004, 127:420-430.
11. Biskup S., Mueller J.C., Sharma M., Lichtner P., Zimprich A., Berg D., Wullner U., Illig T., Meitinger T., Gasser T. Common variants of LRRK2 are not associated with sporadic Parkinson's disease. Ann Neurol 2005, 58:905-908.
12. Bonifati V., Breedveld G.J., Squitieri F., Vanacore N., Brustenghi P., Harhangi B.S., Montagna P., Cannella M., Fabbrini G., Rizzu P., van Duijn C.M., Oostra B.A., Meco G., Heutink P. Localization of autosomal recessive early-onset parkinsonism to chromosome 1p36 (PARK7) in an independent dataset. Ann Neurol 2002, 51:253-256.
13. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
14. Bonifati V., Rizzu P., van Baren M.J., Schaap O., Breedveld G.J., Krieger E., Dekker M.C., Squitieri F., Ibanez P., Joosse M., van Dongen J.W., Vanacore N., van Swieten J.C., Brice A., Meco G., van Duijn C.M., Oostra B.A., Heutink P. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003, 299:256-259.
15. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
16. Canet-Aviles R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., Cookson M.R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 2004, 101:9103-9108.
17. Cannon S.C. Paying the price at the pump: Dystonia from mutations in a Na+/K+-ATPase. Neuron 2004, 43:153-154.
18. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., Destee A. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004, 364:1167-1169.
19. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., Van den Broeck M., Cuijt I., Vennekens K., De Deyn P.P., Kumar-Singh S., Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006, 442:920-924.
20. de Carvalho Aguiar P., Sweadner K.J., Penniston J.T., Zaremba J., Liu L., Caton M., Linazasoro G., Borg M., Tijssen M.A., Bressman S.B., Dobyns W.B., Brashear A., Ozelius L.J. Mutations in the Na+/K+-ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 2004, 43:169-175.
21. Delacourte A., Buee L. Normal and pathological Tau proteins as factors for microtubule assembly. Int Rev Cytol 1997, 171:167-224.
22. Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., Guedes L., Fabrizio E., Manfredi M., Vanacore N., Goldwurm S., Breedveld G., Sampaio C., Meco G., Barbosa E., Oostra B.A., Bonifati V. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005, 365:412-415.
23. Di Fonzo A., Wu-Chou Y.H., Lu C.S., van Doeselaar M., Simons E.J., Rohe C.F., Chang H.C., Chen R.S., Weng Y.H., Vanacore N., Breedveld G.J., Oostra B.A., Bonifati V. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 2006, 7:133-138.
24. Di Fonzo A., Chien H.F., Socal M., Giraudo S., Tassorelli C., Iliceto G., Fabbrini G., Marconi R., Fincati E., Abbruzzese G., Marini P., Squitieri F., Horstink M.W., Montagna P., Libera A.D., Stocchi F., Goldwurm S., Ferreira J.J., Meco G., Martignoni E., Lopiano L., Jardim L.B., Oostra B.A., Barbosa E.R., Bonifati V. ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 2007, 68:1557-1562.
25. Dickson D.W., Feany M.B., Yen S.H., Mattiace L.A., Davies P. Cytoskeletal pathology in non-Alzheimer degenerative dementia: New lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration. J Neural Transm Suppl 1996, 47:31-46.
26. Djarmati A., Hedrich K., Svetel M., Lohnau T., Schwinger E., Romac S., Pramstaller P.P., Kostic V., Klein C. Heterozygous PINK1 mutations: A susceptibility factor for Parkinson disease?. Mov Disord 2006, 21:1526-1530.
27. Dobyns W.B., Ozelius L.J., Kramer P.L., Brashear A., Farlow M.R., Perry T.R., Walsh L.E., Kasarskis E.J., Butler I.J., Breakefield X.O. Rapid-onset dystonia-parkinsonism. Neurology 1993, 43:2596-2602.
28. Elbaz A., Nelson L.M., Payami H., Ioannidis J.P., Fiske B.K., Annesi G., Carmine Belin A., Factor S.A., Ferrarese C., Hadjigeorgiou G.M., Higgins D.S., Kawakami H., Kruger R., Marder K.S., Mayeux R.P., Mellick G.D., Nutt J.G., Ritz B., Samii A., Tanner C.M., Van Broeckhoven C., Van Den Eeden S.K., Wirdefeldt K., Zabetian C.P., Dehem M., Montimurro J.S., Southwick A., Myers R.M., Trikalinos T.A. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: A large-scale international study. Lancet Neurol 2006, 5:917-923.
29. Fallon L., Belanger C.M., Corera A.T., Kontogiannea M., Regan-Klapisz E., Moreau F., Voortman J., Haber M., Rouleau G., Thorarinsdottir T., Brice A., van Bergen En Henegouwen P.M., Fon E.A. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat Cell Biol 2006, 8:834-842.
30. Farrer M., Wavrant-De Vrieze F., Crook R., Boles L., Perez-Tur J., Hardy J., Johnson W.G., Steele J., Maraganore D., Gwinn K., Lynch T. Low frequency of alpha-synuclein mutations in familial Parkinson's disease. Ann Neurol 1998, 43:394-397.
31. Farrer M., Destee T., Becquet E., Wavrant-De Vrieze F., Mouroux V., Richard F., Defebvre L., Lincoln S., Hardy J., Amouyel P., Chartier-Harlin M.C. Linkage exclusion in French families with probable Parkinson's disease. Mov Disord 2000, 15:1075-1083.
32. Farrer M., Chan P., Chen R., Tan L., Lincoln S., Hernandez D., Forno L., Gwinn-Hardy K., Petrucelli L., Hussey J., Singleton A., Tanner C., Hardy J., Langston J.W. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001, 50:293-300.
33. Farrer M., Kachergus J., Forno L., Lincoln S., Wang D.S., Hulihan M., Maraganore D., Gwinn-Hardy K., Wszolek Z., Dickson D., Langston J.W. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004, 55:174-179.
34. Farrer M., Ross O.A., Stone J.T. LRRK2-related Parkinson's disease in GeneReviews at GeneTests: Medical Genetics Information Resource [database online] 2006, Copyright, University of Washington, Seattle, 1997-2006. Available at http://www.genetests.org.
35. Farrer M.J. Genetics of Parkinson disease: Paradigm shifts and future prospects. Nat Rev Genet 2006, 7:306-318.
36. Farrer M.J., Haugarvoll K., Ross O.A., Stone J.T., Milkovic N.M., Cobb S.A., Whittle A.J., Lincoln S.J., Hulihan M.M., Heckman M.G., White L.R., Aasly J.O., Gibson J.M., Gosal D., Lynch T., Wszolek Z.K., Uitti R.J., Toft M. Genome-wide association, Parkinson disease, and PARK10. Am J Hum Genet 2006, 78:1084-1088. author reply 1092-4.
37. Farrer M.J., Stone J.T., Lin C.H., Dachsel J.C., Hulihan M.M., Haugarvoll K., Ross O.A., Wu R.M. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat Disord 2007, 13:89-92.
38. Fuchs J., Nilsson C., Kachergus J., Munz M., Larsson E.M., Schule B., Langston J.W., Middleton F.A., Ross O.A., Hulihan M., Gasser T., Farrer M.J. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007, 68:916-922.
39. Funayama M., Hasegawa K., Kowa H., Saito M., Tsuji S., Obata F. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002, 51:296-301.
40. Funayama M., Li Y., Tomiyama H., Yoshino H., Imamichi Y., Yamamoto M., Murata M., Toda T., Mizuno Y., Hattori N. Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population. Neuroreport 2007, 18:273-275.
41. Fung H.C., Scholz S., Matarin M., Simon-Sanchez J., Hernandez D., Britton A., Gibbs J.R., Langefeld C., Stiegert M.L., Schymick J., Okun M.S., Mandel R.J., Fernandez H.H., Foote K.D., Rodriguez R.L., Peckham E., De Vrieze F.W., Gwinn-Hardy K., Hardy J.A., Singleton A. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: First stage analysis and public release of data. Lancet Neurol 2006, 5:911-916.
42. Gass J., Cannon A., Mackenzie I.R., Boeve B., Baker M., Adamson J., Crook R., Melquist S., Kuntz K., Petersen R., Josephs K., Pickering-Brown S.M., Graff-Radford N., Uitti R., Dickson D., Wszolek Z., Gonzalez J., Beach T.G., Bigio E., Johnson N., Weintraub S., Mesulam M., White C.L., Woodruff B., Caselli R., Hsiung G.Y., Feldman H., Knopman D., Hutton M., Rademakers R. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 2006, 15:2988-3001.
43. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000, 290:985-989.
44. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., Shaw K., Bhatia K.P., Bonifati V., Quinn N.P., Lynch J., Healy D.G., Holton J.L., Revesz T., Wood N.W. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005, 365:415-416.
45. Gloeckner C.J., Kinkl N., Schumacher A., Braun R.J., O'Neill E., Meitinger T., Kolch W., Prokisch H., Ueffing M. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 2006, 15:223-232.
46. Goedert M., Spillantini M.G., Jakes R., Rutherford D., Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989, 3:519-526.
47. Goedert M., Crowther R.A., Spillantini M.G. Tau mutations cause frontotemporal dementias. Neuron 1998, 21:955-958.
48. Goldberg M.S., Pisani A., Haburcak M., Vortherms T.A., Kitada T., Costa C., Tong Y., Martella G., Tscherter A., Martins A., Bernardi G., Roth B.L., Pothos E.N., Calabresi P., Shen J. Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 2005, 45:489-496.
49. Hague S., Rogaeva E., Hernandez D., Gulick C., Singleton A., Hanson M., Johnson J., Weiser R., Gallardo M., Ravina B., Gwinn-Hardy K., Crawley A., St George-Hyslop P.H., Lang A.E., Heutink P., Bonifati V., Hardy J. Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. Ann Neurol 2003, 54:271-274.
50. Hampshire D.J., Roberts E., Crow Y., Bond J., Mubaidin A., Wriekat A.L., Al-Din A., Woods C.G. Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. J Med Genet 2001, 38:680-682.
51. He Z., Bateman A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med 2003, 81:600-612.
52. He Z., Ong C.H., Halper J., Bateman A. Progranulin is a mediator of the wound response. Nat Med 2003, 9:225-229.
53. Healy D.G., Abou-Sleiman P.M., Gibson J.M., Ross O.A., Jain S., Gandhi S., Gosal D., Muqit M.M., Wood N.W., Lynch T. PINK1 (PARK6) associated Parkinson disease in Ireland. Neurology 2004, 63:1486-1488.
54. Healy D.G., Abou-Sleiman P.M., Casas J.P., Ahmadi K.R., Lynch T., Gandhi S., Muqit M.M., Foltynie T., Barker R., Bhatia K.P., Quinn N.P., Lees A.J., Gibson J.M., Holton J.L., Revesz T., Goldstein D.B., Wood N.W. UCHL-1 is not a Parkinson's disease susceptibility gene. Ann Neurol 2006, 59:627-633.
55. Hutton M. Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms. Neurology 2001, 56:S21-sS25.
56. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Heutink P., et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705.
57. Ibanez P., Bonnet A.M., Debarges B., Lohmann E., Tison F., Pollak P., Agid Y., Durr A., Brice A. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004, 364:1169-1171.
58. Ishihara L., Warren L., Gibson R., Amouri R., Lesage S., Durr A., Tazir M., Wszolek Z.K., Uitti R.J., Nichols W.C., Griffith A., Hattori N., Leppert D., Watts R., Zabetian C.P., Foroud T.M., Farrer M.J., Brice A., Middleton L., Hentati F. Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Arch Neurol 2006, 63:1250-1254.
59. Ishikawa A., Tsuji S. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 1996, 47:160-166.
60. Ito G., Okai T., Fujino G., Takeda K., Ichijo H., Katada T., Iwatsubo T. GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease. Biochemistry 2007, 46:1380-1388.
61. Jaleel M., Nichols R.J., Deak M., Campbell D.G., Gillardon F., Knebel A., Alessi D.R. LRRK2 phosphorylates moesin at Thr558; characterisation of how Parkinson's disease mutants affect kinase activity. Biochem J. 2007, 43.
62. Johnson J., Hague S.M., Hanson M., Gibson A., Wilson K.E., Evans E.W., Singleton A.A., McInerney-Leo A., Nussbaum R.L., Hernandez D.G., Gallardo M., McKeith I.G., Burn D.J., Ryu M., Hellstrom O., Ravina B., Eerola J., Perry R.H., Jaros E., Tienari P., Weiser R., Gwinn-Hardy K., Morris C.M., Hardy J., Singleton A.B. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 2004, 63:554-556.
63. Kachergus J., Mata I.F., Hulihan M., Taylor J.P., Lincoln S., Aasly J., Gibson J.M., Ross O.A., Lynch T., Wiley J., Payami H., Nutt J., Maraganore D.M., Czyzewski K., Styczynska M., Wszolek Z.K., Farrer M.J., Toft M. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: Evidence of a common founder across European populations. Am J Hum Genet 2005, 76:672-680.
64. Kamm C., Leung J., Joseph S., Dobyns W.B., Brashear A., Breakefield X.O., Ozelius L.J. Refined linkage to the RDP/DYT12 locus on 19q13.2 and evaluation of GRIK5 as a candidate gene. Mov Disord 2004, 19:845-847.
65. Kann M., Jacobs H., Mohrmann K., Schumacher K., Hedrich K., Garrels J., Wiegers K., Schwinger E., Pramstaller P.P., Breakefield X.O., Ozelius L.J., Vieregge P., Klein C. Role of parkin mutations in 111 community-based patients with early-onset parkinsonism. Ann Neurol 2002, 51:621-625.
66. Kay D.M., Moran D., Moses L., Poorkaj P., Zabetian C.P., Nutt J., Factor S.A., Yu C.E., Montimurro J.S., Keefe R.G., Schellenberg G.D., Payami H. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Ann Neurol 2007, 61:47-54.
67. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
68. Kosik K.S., Orecchio L.D., Bakalis S., Neve R.L. Developmentally regulated expression of specific tau sequences. Neuron 1989, 2:1389-1397.
69. Kramer P.L., Mineta M., Klein C., Schilling K., de Leon D., Farlow M.R., Breakefield X.O., Bressman S.B., Dobyns W.B., Ozelius L.J., Brashear A. Rapid-onset dystonia-parkinsonism: Linkage to chromosome 19q13. Ann Neurol 1999, 46:176-182.
70. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998, 18:106-108.
71. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M.J., Jonnalagada S., Chernova T., Dehejia A., Lavedan C., Gasser T., Steinbach P.J., Wilkinson K.D., Polymeropoulos M.H. The ubiquitin pathway in Parkinson's disease. Nature 1998, 395:451-452.
72. Lesage S., Durr A., Tazir M., Lohmann E., Leutenegger A.L., Janin S., Pollak P., Brice A. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 2006, 354:422-423.
73. Lesage S., Magali P., Lohmann E., Lacomblez L., Teive H., Janin S., Cousin P.Y., Durr A., Brice A. Deletion of the parkin and PACRG gene promoter in early-onset parkinsonism. Hum Mutat 2007, 28:27-32.
74. Lewis P.A., Greggio E., Beilina A., Jain S., Baker A., Cookson M.R. The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem Biophys Res Commun 2007, 357:668-671.
75. Lincoln S., Vaughan J., Wood N., Baker M., Adamson J., Gwinn-Hardy K., Lynch T., Hardy J., Farrer M. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. Neuroreport 1999, 10:427-429.
76. Lincoln S.J., Maraganore D.M., Lesnick T.G., Bounds R., de Andrade M., Bower J.H., Hardy J.A., Farrer M.J. Parkin variants in North American Parkinson's disease: Cases and controls. Mov Disord 2003, 18:1306-1311.
77. Lockhart P.J., Kachergus J., Lincoln S., Hulihan M., Bisceglio G., Thomas N., Dickson D., Farrer M.J. Multiplication of the alpha-synuclein gene is not a common disease mechanism in Lewy body disease. J Mol Neurosci 2004, 24:337-342.
78. Lucking C.B., Durr A., Bonifati V., Vaughan J., De Michele G., Gasser T., Harhangi B.S., Meco G., Denefle P., Wood N.W., Agid Y., Brice A. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 2000, 342:1560-1567.
79. MacLeod D., Dowman J., Hammond R., Leete T., Inoue K., Abeliovich A. The familial Parkinsonism gene LRRK2 regulates neurite process morphology. Neuron 2006, 52:587-593.
80. Manning-Bog A.B., McCormack A.L., Li J., Uversky V.N., Fink A.L., Di Monte D.A. The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: Paraquat and alpha-synuclein. J Biol Chem 2002, 277:1641-1644.
81. Maraganore D.M., Farrer M.J., Hardy J.A., Lincoln S.J., McDonnell S.K., Rocca W.A. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology 1999, 53:1858-1860.
82. Maraganore D.M., Lesnick T.G., Elbaz A., Chartier-Harlin M.C., Gasser T., Kruger R., Hattori N., Mellick G.D., Quattrone A., Satoh J., Toda T., Wang J., Ioannidis J.P., de Andrade M., Rocca W.A. UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol 2004, 55:512-521.
83. Maraganore D.M., Wilkes K., Lesnick T.G., Strain K.J., de Andrade M., Rocca W.A., Bower J.H., Ahlskog J.E., Lincoln S., Farrer M.J. A limited role for DJ1 in Parkinson disease susceptibility. Neurology 2004, 63:550-553.
84. Maraganore D.M., de Andrade M., Elbaz A., Farrer M.J., Ioannidis J.P., Kruger R., Rocca W.A., Schneider N.K., Lesnick T.G., Lincoln S.J., Hulihan M.M., Aasly J.O., Ashizawa T., Chartier-Harlin M.C., Checkoway H., Ferrarese C., Hadjigeorgiou G., Hattori N., Kawakami H., Lambert J.C., Lynch T., Mellick G.D., Papapetropoulos S., Parsian A., Quattrone A., Riess O., Tan E.K., Van Broeckhoven C. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 2006, 296:661-670.
85. Maraganore D.M., de Andrade M., Lesnick T.G., Strain K.J., Farrer M.J., Rocca W.A., Pant P.V., Frazer K.A., Cox D.R., Ballinger D.G. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005, 77:685-693.
86. Marongiu R., Brancati F., Antonini A., Ialongo T., Ceccarini C., Scarciolla O., Capalbo A., Benti R., Pezzoli G., Dallapiccola B., Goldwurm S., Valente E.M. Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum. Hum Mutat 2007, 28:98.
87. Mata I.F., Alvarez V., Garcia-Moreira V., Guisasola L.M., Ribacoba R., Salvador C., Blazquez M., Sarmiento R.G., Lahoz C.H., Menes B.B., Garcia E.C. Single-nucleotide polymorphisms in the promoter region of the PARKIN gene and Parkinson's disease. Neurosci Lett 2002, 329:149-152.
88. Mata I.F., Lockhart P.J., Farrer M.J. Parkin genetics: One model for Parkinson's disease. Hum Mol Genet 2004, 13(Spec No 1):R127-rR133.
89. Mata I.F., Kachergus J.M., Taylor J.P., Lincoln S., Aasly J., Lynch T., Hulihan M.M., Cobb S.A., Wu R.M., Lu C.S., Lahoz C., Wszolek Z.K., Farrer M.J. Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 2005, 6:171-177.
90. Mata I.F., Wedemeyer W.J., Farrer M.J., Taylor J.P., Gallo K.A. LRRK2 in Parkinson's disease: Protein domains and functional insights. Trends Neurosci 2006, 29:286-293.
91. Matsumine H., Saito M., Shimoda-Matsubayashi S., Tanaka H., Ishikawa A., Nakagawa-Hattori Y., Yokochi M., Kobayashi T., Igarashi S., Takano H., Sanpei K., Koike R., Mori H., Kondo T., Mizutani Y., Schaffer A.A., Yamamura Y., Nakamura S., Kuzuhara S., Tsuji S., Mizuno Y. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am J Hum Genet 1997, 60:588-596.
92. McGrail K.M., Phillips J.M., Sweadner K.J. Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: Both neurons and glia can express more than one Na,K-ATPase. J Neurosci 1991, 11:381-391.
93. Miller D.W., Ahmad R., Hague S., Baptista M.J., Canet-Aviles R., McLendon C., Carter D.M., Zhu P.P., Stadler J., Chandran J., Klinefelter G.R., Blackstone C., Cookson M.R. L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system. J Biol Chem 2003, 278:36588-36595.
94. Mitsumoto A., Nakagawa Y. DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic Res 2001, 35:885-893.
95. Mizuta I., Satake W., Nakabayashi Y., Ito C., Suzuki S., Momose Y., Nagai Y., Oka A., Inoko H., Fukae J., Saito Y., Sawabe M., Murayama S., Yamamoto M., Hattori N., Murata M., Toda T. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum Mol Genet 2006, 15:1151-1158.
96. Momose Y., Murata M., Kobayashi K., Tachikawa M., Nakabayashi Y., Kanazawa I., Toda T. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol 2002, 51:133-136.
97. Morris C.M., O'Brien K.K., Gibson A.M., Hardy J.A., Singleton A.B. Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease. Neurosci Lett 2003, 352:151-153.
98. Mueller J.C., Fuchs J., Hofer A., Zimprich A., Lichtner P., Illig T., Berg D., Wullner U., Meitinger T., Gasser T. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann Neurol 2005, 57:535-541.
99. Muenter M.D., Forno L.S., Hornykiewicz O., Kish S.J., Maraganore D.M., Caselli R.J., Okazaki H., Howard F.M., Snow B.J., Calne D.B. Hereditary form of parkinsonism - dementia. Ann Neurol 1998, 43:768-781.
100. Najim al-Din A.S., Wriekat A., Mubaidin A., Dasouki M., Hiari M. Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurol Scand 1994, 89:347-352.
101. Nemeth A.H. The genetics of primary dystonias and related disorders. Brain 2002, 125:695-721.
102. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
103. Nichols W.C., Pankratz N., Hernandez D., Paisan-Ruiz C., Jain S., Halter C.A., Michaels V.E., Reed T., Rudolph A., Shults C.W., Singleton A., Foroud T. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005, 365:410-412.
104. Nishioka K., Hayashi S., Farrer M.J., Singleton A.B., Yoshino H., Imai H., Kitami T., Sato K., Kuroda R., Tomiyama H., Mizoguchi K., Murata M., Toda T., Imoto I., Inazawa J., Mizuno Y., Hattori N. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease. Ann Neurol 2006, 59:298-309.
105. Ozelius L.J., Senthil G., Saunders-Pullman R., Ohmann E., Deligtisch A., Tagliati M., Hunt A.L., Klein C., Henick B., Hailpern S.M., Lipton R.B., Soto-Valencia J., Risch N., Bressman S.B. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 2006, 354:424-425.
106. Paglini G., Kunda P., Quiroga S., Kosik K., Caceres A. Suppression of radixin and moesin alters growth cone morphology, motility, and process formation in primary cultured neurons. J Cell Biol 1998, 143:443-455.
107. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., Lopez de Munain A., Aparicio S., Gil A.M., Khan N., Johnson J., Martinez J.R., Nicholl D., Carrera I.M., Pena A.S., de Silva R., Lees A., Marti-Masso J.F., Perez-Tur J., Wood N.W., Singleton A.B. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004, 44:595-600.
108. Paisan-Ruiz C., Lang A.E., Kawarai T., Sato C., Salehi-Rad S., Fisman G.K., Al-Khairallah T., St George-Hyslop P., Singleton A., Rogaeva E. LRRK2 gene in Parkinson disease: Mutation analysis and case control association study. Neurology 2005, 65:696-700.
109. Paisan-Ruiz C., Evans E.W., Jain S., Xiromerisiou G., Gibbs J.R., Eerola J., Gourbali V., Hellstrom O., Duckworth J., Papadimitriou A., Tienari P.J., Hadjigeorgiou G.M., Singleton A.B. Testing association between LRRK2 and Parkinson's disease and investigating linkage disequilibrium. J Med Genet 2006, 43:e9.
110. Pals P., Lincoln S., Manning J., Heckman M., Skipper L., Hulihan M., Van den Broeck M., De Pooter T., Cras P., Crook J., Van Broeckhoven C., Farrer M.J. Alpha-synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol 2004, 56:591-595.
111. Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 2002, 14:223-236. discussion 222.
112. Piccini P., Burn D.J., Ceravolo R., Maraganore D., Brooks D.J. The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol 1999, 45:577-582.
113. Pittock S.J., Joyce C., O'Keane V., Hugle B., Hardiman M.O., Brett F., Green A.J., Barton D.E., King M.D., Webb D.W. Rapid-onset dystonia-parkinsonism: A clinical and genetic analysis of a new kindred. Neurology 2000, 55:991-995.
114. Polymeropoulos M.H., Higgins J.J., Golbe L.I., Johnson W.G., Ide S.E., Di Iorio G., Sanges G., Stenroos E.S., Pho L.T., Schaffer A.A., Lazzarini A.M., Nussbaum R.L., Duvoisin R.C. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996, 274:1197-1199.
115. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
116. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998, 43:815-825.
117. Poorkaj P., Kas A., D'Souza I., Zhou Y., Pham Q., Stone M., Olson M.V., Schellenberg G.D. A genomic sequence analysis of the mouse and human microtubule-associated protein tau. Mamm Genome 2001, 12:700-712.
118. Ramirez A., Heimbach A., Grundemann J., Stiller B., Hampshire D., Cid L.P., Goebel I., Mubaidin A.F., Wriekat A.L., Roeper J., Al-Din A., Hillmer A.M., Karsak M., Liss B., Woods C.G., Behrens M.I., Kubisch C. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 2006, 38:1184-1191.
119. Risch N.J. Searching for genetic determinants in the new millennium. Nature 2000, 405:847-856.
120. Rizzu P., Hinkle D.A., Zhukareva V., Bonifati V., Severijnen L.A., Martinez D., Ravid R., Kamphorst W., Eberwine J.H., Lee V.M., Trojanowski J.Q., Heutink P. DJ-1 colocalizes with tau inclusions: A link between parkinsonism and dementia. Ann Neurol 2004, 55:113-118.
121. Ross O.A., Toft M., Whittle A.J., Johnson J.L., Papapetropoulos S., Mash D.C., Litvan I., Gordon M.F., Wszolek Z.K., Farrer M.J., Dickson D.W. Lrrk2 and Lewy body disease. Ann Neurol 2006, 59:388-393.
122. Ross O.A., Farrer M.J., Wu R.M. Common variants in Parkinson's disease. Mov Disord 2007, 22:899-900.
123. Ross O.A., Haugarvoll K., Stone J.T., Heckman M.G., White L.R., Aasly J.O., Mark Gibson J., Lynch T., Wszolek Z.K., Uitti R.J., Farrer M.J. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism Relat Disord 2007, 13:386-388.
124. Satoh J., Kuroda Y. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population. J Neurol Sci 2001, 189:113-117.
125. Semchuk K.M., Love E.J., Lee R.G. Parkinson's disease: A test of the multifactorial etiologic hypothesis. Neurology 1993, 43:1173-1180.
126. Shimura H., Hattori N., Kubo S., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K., Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000, 25:302-305.
127. Sim C.H., Lio D.S., Mok S.S., Masters C.L., Hill A.F., Culvenor J.G.,
128. Simon D.K., Lin M.T., Pascual-Leone A. "Nature versus nurture" and incompletely penetrant mutations. J Neurol Neurosurg Psychiatry 2002, 72:686-689.
129. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
130. Skipper L., Wilkes K., Toft M., Baker M., Lincoln S., Hulihan M., Ross O.A., Hutton M., Aasly J., Farrer M. Linkage disequilibrium and association of MAPT H1 in Parkinson disease. Am J Hum Genet 2004, 75:669-677.
131. Skipper L., Li Y., Bonnard C., Pavanni R., Yih Y., Chua E., Sung W.K., Tan L., Wong M.C., Tan E.K., Liu J. Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease. Hum Mol Genet 2005, 14:3549-3556.
132. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
133. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998, 95:7737-7741.
134. Strauss K.M., Martins L.M., Plun-Favreau H., Marx F.P., Kautzmann S., Berg D., Gasser T., Wszolek Z., Muller T., Bornemann A., Wolburg H., Downward J., Riess O., Schulz J.B., Kruger R. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 2005, 14:2099-2111.
135. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001, 8:613-621.
136. Takahashi H., Ohama E., Suzuki S., Horikawa Y., Ishikawa A., Morita T., Tsuji S., Ikuta F. Familial juvenile parkinsonism: Clinical and pathologic study in a family. Neurology 1994, 44:437-441.
137. Tang B., Xiong H., Sun P., Zhang Y., Wang D., Hu Z., Zhu Z., Ma H., Pan Q., Xia J.H., Xia K., Zhang Z. Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum Mol Genet 2006, 15:1816-1825.
138. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., Langston J.W. Parkinson disease in twins: An etiologic study. JAMA 1999, 281:341-346.
139. Tassin J., Durr A., Bonnet A.M., Gil R., Vidailhet M., Lucking C.B., Goas J.Y., Durif F., Abada M., Echenne B., Motte J., Lagueny A., Lacomblez L., Jedynak P., Bartholome B., Agid Y., Brice A. Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?. Brain 2000, 123(Pt 6):1112-1121.
140. Valente E.M., Bentivoglio A.R., Dixon P.H., Ferraris A., Ialongo T., Frontali M., Albanese A., Wood N.W. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet 2001, 68:895-900.
141. Valente E.M., Brancati F., Ferraris A., Graham E.A., Davis M.B., Breteler M.M., Gasser T., Bonifati V., Bentivoglio A.R., De Michele G., Durr A., Cortelli P., Wassilowsky D., Harhangi B.S., Rawal N., Caputo V., Filla A., Meco G., Oostra B.A., Brice A., Albanese A., Dallapiccola B., Wood N.W. Park6-linked parkinsonism occurs in several European families. Ann Neurol 2002, 51:14-18.
142. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004, 15:15.
143. Valente E.M., Salvi S., Ialongo T., Marongiu R., Elia A.E., Caputo V., Romito L., Albanese A., Dallapiccola B., Bentivoglio A.R. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 2004, 56:336-341.
144. van Duijn C.M., Dekker M.C., Bonifati V., Galjaard R.J., Houwing-Duistermaat J.J., Snijders P.J., Testers L., Breedveld G.J., Horstink M., Sandkuijl L.A., van Swieten J.C., Oostra B.A., Heutink P. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet 2001, 69:629-634.
145. Vaughan J.R., Farrer M.J., Wszolek Z.K., Gasser T., Durr A., Agid Y., Bonifati V., DeMichele G., Volpe G., Lincoln S., Breteler M., Meco G., Brice A., Marsden C.D., Hardy J., Wood N.W. Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD). Hum Mol Genet 1998, 7:751-753.
146. West A., Farrer M., Petrucelli L., Cookson M., Lockhart P., Hardy J. Identification and characterization of the human parkin gene promoter. J Neurochem 2001, 78:1146-1152.
147. West A., Periquet M., Lincoln S., Lucking C.B., Nicholl D., Bonifati V., Rawal N., Gasser T., Lohmann E., Deleuze J.F., Maraganore D., Levey A., Wood N., Durr A., Hardy J., Brice A., Farrer M. Complex relationship between Parkin mutations and Parkinson disease. Am J Med Genet 2002, 114:584-591.
148. West A.B., Maraganore D., Crook J., Lesnick T., Lockhart P.J., Wilkes K.M., Kapatos G., Hardy J.A., Farrer M.J. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum Mol Genet 2002, 11:2787-2792.
149. West A.B., Moore D.J., Biskup S., Bugayenko A., Smith W.W., Ross C.A., Dawson V.L., Dawson T.M. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci USA 2005, 102:16842-16847.
150. Wirdefeldt K., Gatz M., Schalling M., Pedersen N.L. No evidence for heritability of Parkinson disease in Swedish twins. Neurology 2004, 63:305-311.
151. Zabetian C.P., Hutter C.M., Factor S.A., Nutt J.G., Higgins D.S., Griffith A., Roberts J.W., Leis B.C., Kay D.M., Yearout D., Montimurro J.S., Edwards K.L., Samii A., Payami H. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann Neurol 2007, 62:137-144.
152. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B., Llorens V., Gomez Tortosa E., del Ser T., Munoz D.G., de Yebenes J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 2004, 55:164-173.
153. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Muller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004, 44:601-607.
154. Zimprich A., Muller-Myhsok B., Farrer M., Leitner P., Sharma M., Hulihan M., Lockhart P., Strongosky A., Kachergus J., Calne D.B., Stoessl J., Uitti R.J., Pfeiffer R.F., Trenkwalder C., Homann N., Ott E., Wenzel K., Asmus F., Hardy J., Wszolek Z., Gasser T. The PARK8 locus in autosomal dominant parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 2004, 74:11-19.